| Metric | Value ($ M) | Q2 FY26 | Q3 FY25 |
|---|---|---|---|
| Revenue | 1.1K | 1.4% | 0.6% |
| Total Income | 1.1K | 1.4% | 0.6% |
| Expenditure | 844.20 | 24.1% | 4.6% |
| PBT | 201.80 | 516.9% | 32.9% |
| Net Profit | 432.80 | 655.6% | 340.3% |
| OPM | 20.82% | 23.69pp | 4.25pp |
| NPM | 40.59% | 47.80pp | 31.32pp |
| EPS | 2.24 | 660.0% | 357.1% |
CooperCompanies Announces Third Quarter 2026 Results
10 Sept 2026 · 10 Sept, 2:11 am
Summary
The Cooper Companies, Inc. reported third quarter fiscal 2026 revenue of $1.066 billion, a 1% increase year-over-year. The company saw a significant increase in GAAP diluted EPS to $2.24, primarily due to a $307.2 million tax benefit, while non-GAAP diluted EPS grew 4% to $1.15. Free cash flow surged 66% to $273.0 million. Management noted solid fertility growth at CooperSurgical but acknowledged that proactive inventory reduction at CooperVision weighed on results and is expected to impact the fourth quarter.
Key Highlights
- 1
Revenue increased 1% year-over-year to $1.066 billion for the third quarter of fiscal 2026.
- 2
GAAP diluted earnings per share (EPS) was $2.24, compared to $0.49 in the prior year's third quarter, significantly boosted by a $307.2 million discrete tax benefit.
- 3
Non-GAAP diluted EPS was $1.15, representing a 4% increase from the prior year's third quarter.
- 4
Free cash flow increased by 66% to $273.0 million in the third quarter of fiscal 2026.
- 5
CooperSurgical revenue grew 2% year-over-year to $349.2 million, with fertility revenue up 3%.
- 6
CooperVision revenue remained comparable year-over-year at $717.0 million, impacted by proactive U.S. channel inventory reduction.
Management Comments
Al White
This quarter included a number of notable developments including earnings exceeding expectations, record free cash flow, solid fertility growth at CooperSurgical, and a favorable completion of a significant tax matter. At CooperVision, however, we proactively reduced U.S. channel inventory that weighed on our results and will continue to impact Q4. Following the completion of the strategic review, we are focused on profitable growth, strong cash flow generation, disciplined capital allocation, and maximizing long-term shareholder value. Over the past year, we conducted a rigorous review of every aspect of our business with a singular focus on unlocking value. The process identified meaningful opportunities to enhance execution, sharpen our strategic focus and accelerate innovation. We have proactively taken steps to address these items and are in the process of evaluating additional options. Looking ahead, we will continue pursuing the most value-accretive options available to us.
Informational and educational content only. Not investment advice.